Innovative clinical trials focusing on ER+/HER2- metastatic breast cancer treatment combinations. Research evaluates the effectiveness of combining palbociclib with endocrine therapy, with particular attention to monitoring treatment responses.

Hormone Therapy Optimization
Treatment Safety Assessment
Mutation Detection Studies

Studies aim to improve treatment strategies through careful monitoring of circulating tumor DNA and mutation patterns.

02 Prostate Cancer Studies

Research focusing on post-surgical treatment options for prostatic adenocarcinoma patients. Studies evaluate long-term effectiveness of adjuvant hormonal treatments following radical prostatectomy.

Post-Surgery Treatment
Recurrence Prevention
Long-term Survival Analysis

Investigations center on extended hormone therapy protocols to prevent cancer recurrence in high-risk patients.

Back to France All countries

Clinical trials in La Seyne-sur-Mer

3 trials in La Seyne-sur-Mer

Triple negative breast cancer

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Prostate cancer

Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

Hormone receptor positive HER2 negative breast cancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Filter the trials

Other cities in France

Clinical research in La Seyne-sur-Mer

Prefer not to search? Our Concierge searches the trials for you.